Metabolic Associated Steatotic Liver Disease Clinical Trials
3 recruiting trials for Metabolic Associated Steatotic Liver Disease. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGEarly Phase 1NCT06113003
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
Persons with human immunodeficiency virus (HIV) have higher risk of developing fatty liver disease (NAFLD) than HIV-negative persons but the reasons for this discrepancy are not...
Sponsor: Vanderbilt University Medical CenterEnrolling: 631 location
RECRUITINGPhase 2NCT07481734
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
This randomized, double-blind, placebo-controlled Phase II study evaluates whether daily subcutaneous tesamorelin (a growth hormone-releasing hormone analog) reduces liver fat in...
Sponsor: Hudson BiotechEnrolling: 1201 location
RECRUITINGNCT07122700
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
The Non-Invasive Biomarkers for Metabolic Liver Disease (NIMBLE) study is a comprehensive, multi-year collaborative effort to standardize, validate and advance the regulatory...
Sponsor: Foundation for the National Institutes of HealthEnrolling: 4004 locations